| |APRIL 20267TOP STORIESNovo Nordisk Reduces Ozempic Price to Compete With Indian GenericsAlembic Pharma Wins USFDA Nod for Generic Mental Health DrugTeva's Biosimilars Expansion Advances With Key FDA ApprovalLupin Receives USFDA Nod for Sugammadex Injection0809C ONT E NT SPharma Financial Year-End Checklist 2026: Key Stats & Compliance10ANALYSISDOLLAR MEDICINEGLOBAL PHARMA HEALTHCARE2228--APRIL EDITIONTOPICAL & TRANSDERMAL MEDICATIONS MANUFACTURER 2026APRIL EDITIONENT PRODUCTS MANUFACTURER 2026Unraveling the New Era of Advanced Plasma-Derived Therapies PLASMAGENBIOSCIENCESVIVEK V KAMATH, CEOCOVER STORY 16APRIL EDITIONBIOTECH COMPANIES IN INDIA 2026
< Page 6 | Page 8 >